Active ingredient: Tamoxifen (as citrate) 20 mg
Dosage form: Film-coated tablets
Pack size: 30 tablets
Manufacturer: Biogaran (France)
Route: Oral use
Tamoxifen is a selective estrogen receptor modulator (SERM) and one of the most studied medicines in oncology. It blocks estrogen receptors in breast tissue, which is why it has been the cornerstone of hormone therapy in hormone-sensitive breast cancer for more than four decades.
The product is produced in France by Biogaran and is a prescription-only medicine managed by an oncologist with regular monitoring.
The usual dose is 20 mg once daily (one tablet), with or without food, at the same time each day. The treatment course is long-term and determined by the oncologist — often several years of adjuvant therapy.
Adjuvant courses often last 5-10 years — the duration is set and reviewed by the oncologist.
Yes, with or without food, at the same time daily.
Tamoxifen increases thrombotic risk and affects the endometrium; regular gynecological and blood monitoring is standard.
Yes, it is a prescription-only oncology medicine.
Yes, in certain hormone-sensitive conditions, as prescribed by a specialist.
Ask a question or inquire about delivery to your country
